175 related articles for article (PubMed ID: 28225892)
1. Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta.
Liu Y; Hou Y; Ma L; Sun C; Pan J; Yang Y; Zhou H; Zhang J
Braz J Med Biol Res; 2017 Feb; 50(3):e6057. PubMed ID: 28225892
[TBL] [Abstract][Full Text] [Related]
2. MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.
Liu Y; Zhou H; Ma L; Hou Y; Pan J; Sun C; Yang Y; Zhang J
Tumour Biol; 2016 Jun; 37(6):8239-48. PubMed ID: 26718213
[TBL] [Abstract][Full Text] [Related]
3. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
4. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
[TBL] [Abstract][Full Text] [Related]
7. Involvement of estrogen receptor beta in ovarian carcinogenesis.
Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
[TBL] [Abstract][Full Text] [Related]
8. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.
Miró AM; Sastre-Serra J; Pons DG; Valle A; Roca P; Oliver J
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):133-9. PubMed ID: 21172438
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.
Zhu J; Lu X; Hua KQ; Sun H; Yu YH; Feng YJ
Arch Gynecol Obstet; 2012 Sep; 286(3):729-37. PubMed ID: 22569715
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
12. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
13. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
O'Donnell AJ; Macleod KG; Burns DJ; Smyth JF; Langdon SP
Endocr Relat Cancer; 2005 Dec; 12(4):851-66. PubMed ID: 16322326
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.
Park SH; Cheung LW; Wong AS; Leung PC
Mol Endocrinol; 2008 Sep; 22(9):2085-98. PubMed ID: 18550773
[TBL] [Abstract][Full Text] [Related]
16. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
17. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.
Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA
Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
